- Beat-to-beat alternating left bundle branch block with QRS morphology variation. [Journal Article]Cardiol J. 2026; 33:e00226080.CJ
- Publisher Full Text (DOI)
- Recommendations on the use of a leadless dual-chamber pacemaker. [Review]Cardiol J. 2026; 33:e00226079.CJ
- Leadless cardiac pacemakers (LPs) represent a significant advancement in cardiac pacing by eliminating the risks associated with traditional transvenous devices. Although single-chamber LPs have been in clinical use, the recent development of dual-chamber systems, such as AVEIR DR, offers synchronized atrial and ventricular pacing without the complications associated with transvenous hardware. De…
- Publisher Full Text (DOI)
- Response to the letter regarding the manuscript entitled: "Lipid-lowering therapy in patients with hypercholesterolemia in terms of the POLSCORE and SCORE2 scales. A single-center retrospective analysis". [Letter]Cardiol J. 2026; 33:e00226063.CJ
- Publisher Full Text (DOI)
- Beyond ejection fraction: why post-MI heart failure needs AI-driven care. [Journal Article]Cardiol J. 2026; 33:e00226070.CJ
- PMC Free PDF
- One-time versus staged multivessel percutaneous coronary intervention in patients with non-ST-segment elevation acute coronary syndrome: a systematic review and meta-analysis. [Systematic Review]
- CONCLUSIONS: For NSTE-ACS patients with multivessel disease, multivessel revascularization in a single procedure may reduce repeat revascularization compared with staged PCI, but the evidence remains limited.
- PMC Free PDF
- Adenosine and ATP differentially control osteogenic gene expression patterns in a cardiac valve cell line. [Journal Article]
- CONCLUSIONS: Purinergic ligands and receptors directly regulate VIC osteogenic differentiation and apoptosis in vitro without exogenous inflammatory stimulation. Modulation of the ATP-Ado axis may represent a therapeutic target to slow CAVD progression.
- PMC Free PDF
- Dual antithrombotic therapy with dabigatran and ticagrelor in patients with acute coronary syndrome and non-valvular atrial fibrillation undergoing percutaneous coronary intervention (ADONIS-PCI): protocol for a randomized controlled pilot trial. [Journal Article]Cardiol J. 2026; 33:e00226073.CJ
- CONCLUSIONS: ADONIS-PCI is among the first randomized evaluations of a reduced-dose long-term ticagrelor strategy combined with dabigatran in patients with AF and ACS undergoing PCI. The trial addresses an important evidence gap in the selection and dosing of P2Y12 inhibition when aspirin is discontinued early in this high-risk population.
- Publisher Full Text (DOI)
- Transcatheter aortic valve-in-valve implantation for failed surgical aortic bioprostheses using the Navitor platform: early outcomes in a consecutive single-center cohort. [Journal Article]
- CONCLUSIONS: Aortic THV-in-SHV with the Navitor platform was associated with acceptable discharge hemodynamics, low rates of clinically relevant PVL, and favorable early safety according to VARC-3. Residual gradients were driven primarily by surgical valve size despite the intra-annular design.
- PMC Free PDF
- Why atrial fibrillation ablation remains underused in EuroAsia Task Force countries: insights from the ESC-EHRA Atlas and a regional survey. [Multicenter Study]
- CONCLUSIONS: Access to AF ablation in EuroAsia Task Force countries is low and heterogeneous. Healthcare financing structure and per-capita health spending may be more important determinants of access than overall expenditure relative to gross domestic product.
- PMC Free PDF
- Aortic valve repair in 2026 - state of the art: what every cardiologist should know. [Review]
- Aortic valve repair (AVr) has evolved into a reproducible surgical strategy for selected patients with aortic regurgitation (AR), offering preservation of native tissue, avoidance of prosthesis-related complications, and favorable long-term outcomes when performed at expert centers. This narrative review summarizes contemporary concepts, indications, preoperative imaging work-up, and procedure se…
- PMC Free PDF